Evidence Repository - Clinical Genome Resources

The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

Variant: NM_000527.5(LDLR):c.1358+7G>A

Curation Version - 1.0
Curation History
JSON LD for Version 1.0

CA033871

375815 (ClinVar)

Gene: LDLR

Condition: hypercholesterolemia, familial

Inheritance Mode: Semidominant inheritance

Link to MONDO

UUID: 5dab2d66-de5b-4e56-8849-666f1badcb9a

Approved on: 2025-02-20

Published on: 2025-06-11

HGVS expressions

NM_000527.5:c.1358+7G>A

NM_000527.5(LDLR):c.1358+7G>A

NC_000019.10:g.11113456G>A

CM000681.2:g.11113456G>A

NC_000019.9:g.11224132G>A

CM000681.1:g.11224132G>A

NC_000019.8:g.11085132G>A

NG_009060.1:g.29076G>A

ENST00000252444.10:c.1616+7G>A

ENST00000559340.2:c.1358+7G>A

ENST00000560467.2:c.1238+7G>A

ENST00000558518.6:c.1358+7G>A

ENST00000252444.9:c.1612+7G>A

ENST00000455727.6:c.854+7G>A

ENST00000535915.5:c.1235+7G>A

ENST00000545707.5:c.977+7G>A

ENST00000557933.5:c.1358+7G>A

ENST00000558013.5:c.1358+7G>A

ENST00000558518.5:c.1358+7G>A

ENST00000559340.1:c.79+7G>A

ENST00000560173.1:n.364G>A

ENST00000560467.1:c.838+7G>A

NM_000527.4:c.1358+7G>A

NM_001195798.1:c.1358+7G>A

NM_001195799.1:c.1235+7G>A

NM_001195800.1:c.854+7G>A

NM_001195803.1:c.977+7G>A

NM_001195798.2:c.1358+7G>A

NM_001195799.2:c.1235+7G>A

NM_001195800.2:c.854+7G>A

NM_001195803.2:c.977+7G>A

Uncertain Significance

PM2 BP4 PP4

PS4

Evidence Links 0

Expert Panel

Familial Hypercholesterolemia VCEP

Criteria Specification Information

Criteria Specification: ClinGen Familial Hypercholesterolemia Expert Panel Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.2

PDF

Criteria Specification Approval History

Criteria Specifications for this VCEP

Evidence submitted by expert panel

Familial Hypercholesterolemia VCEP

The NM_000527.5(LDLR):c.1358+7G>A variant is classified as Uncertain significance - insufficient evidence for Familial Hypercholesterolemia by applying ACMG/AMP evidence codes PM2, PP4 and BP4 as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (specification version 1.2) on 20 February 2025. The supporting evidence is as follows: PM2: PopMax MAF = 0.0001201 (0.012%) in African/African American exomes/genomes (gnomAD v4.1.0). BP4: No REVEL score, splicing evaluation required. Not on splicing limits and no published functional data on splicing found, so BP4 is met. PP4: Variant meets PM2 and is identified in at least 1 index case (1 case with possible FH by Simon Broome criteria from Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies, France), after alternative causes of high cholesterol were excluded.

PM2

PopMax MAF = 0.0001201 (0.012%) in African/African American exomes/genomes (gnomAD v4.1.0).

BP4

No REVEL score, splicing evaluation required. Not on splicing limits and no published functional data on splicing found, so BP4 is met.

PP4

Variant meets PM2 and is identified in at least 1 index case (1 case with possible FH by Simon Broome criteria from Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies, France), after alternative causes of high cholesterol were excluded.

PS4

Variant was found in a single FH proband (Simon Broome possible, Centre de Génétique Moléculaire et Chromosomique).

Curation History

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.